爱尔眼科生物样本库成立于2023年，是爱尔眼科研究所的核心基础设施平台与眼科研究的重要基础资源。2023年12月，样本库正式获批国家人类遗传资源保藏行政许可（国科人遗审字﹝2023﹞BC0080号，图1）。依托研究所国际先进的实验与研究平台，充分整合爱尔眼科医院丰富的临床样本资源与眼科大数据。旨在为眼科学与视觉科学的基础研究、临床研究及转化医学研究，提供系统、坚实且高质量的资源保障。

爱尔眼科生物样本库采用“分布式设计、标准化管理、数字化融合”的建设理念，在全国主要城市及区域的爱尔眼科医院及中心建立“一库多站”模式。通过对接爱尔眼科自主开发的医疗信息系统（AHIS、ALIS和AMER），实现全国范围内生物样本与临床数据的互通互联；在严格保障患者隐私前提下，实现遗传资源全流程可控、可管、可溯源。

在持续积累建库经验、完善运行体系的同时，样本库积极参与行业学术交流与协作，已成为多家国家级行业组织的成员单位，并顺利通过中国医药生物技术协会组织样本库分会组织的全国生物样本库能力验证，在样本采集、处理、存储及质控等关键环节达到行业领先水平。

Aier Eye Biobank, established in 2023 as a core infrastructure platform of the Aier Eye Institute, serves as a foundational resource for ophthalmic research. In December 2023, it obtained the National Administrative Permit for the Preservation of Human Genetic Resources (Approval No. [2023] BC0080). By leveraging the institute’s internationally advanced experimental and research platform, the biobank integrates extensive clinical biospecimens and large-scale ophthalmic healthcare data collected across the Aier Eye Hospital network. It is designed to provide robust and systematic, high-quality resource support for basic research, clinical studies, and translational research in ophthalmology and vision science

The Aier Eye Biobank operates under a “Distributed Design, Standardized Management, and Digital Integration” framework, adopting a “one biobank with multiple stations” structure across Aier Eye Hospitals and key regional centers in China. This structure ensures nationwide interoperability, full data traceability, and rigorous privacy protection through seamless integration with Aier’s proprietary hospital information systems (AHIS, ALIS, and AEMR).

While continuously accumulating biobank construction experience and refining operational systems, the biobank actively participates in academic exchanges and collaborations within the industry. It has become a member unit of multiple national-level industry organizations and successfully passed the National Biobank Proficiency Testing organized by the BioBank Branch of the China Medicinal Biotechnology Association, achieving industry-leading standards in key processes including sample collection, processing, storage, and quality control.

国家人类遗传资源保藏行政许可（国科人遗审字﹝2023﹞BC0080号，图1）

爱尔眼科生物样本库任职人员

于海洋  博士  生物样本库主任

现任中国医药生物技术协会生物样本库分会第五届委员会委员

现任中国非公里医疗机构协会生物样本资源科技分会第一届委员会委员

现任湖南省数字医学学会智能生物样本库分会委员

李  敏  硕士  生物样本库质检员

现任中国非公里医疗机构协会生物样本资源科技分会第一届委员会委员

现任湖南省数字医学学会智能生物样本库分会青年委员

如有业务咨询与交流，请联系：

邮件：Biobank@aierchina.com